Robert D. Legare
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
- Cancer Risks and Factors
- Cancer Treatment and Pharmacology
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 15
- Cancer Treatment and Pharmacology 8
- HER2/EGFR in Cancer Research 5
-
- Breast Cancer Treatment Studies 7
- Co-authors
- Don S. Dizon (13 shared papers)Ashley Stuckey (7 shared papers)Tina Rizack (6 shared papers)C.O. Granai (7 shared papers)Jorge J. Castillo (1 shared paper)Anthony Mega (1 shared paper)Rochelle Strenger (7 shared papers)William M. Sikov (7 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Gynecologic Oncology (5 papers)Blood (2 papers)Cancer Research (2 papers)Obstetrics and Gynecology Clinics of North America (2 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Robert D. Legare
33 papers receiving 805 citations
Peers
Comparison fields: 5 of 69
- Oncology 344
- Cancer Research 165
- Genetics 193
- Reproductive Medicine 55
- Hematology 68
Countries citing papers authored by Robert D. Legare
This map shows the geographic impact of Robert D. Legare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. Legare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. Legare more than expected).
Fields of papers citing papers by Robert D. Legare
This network shows the impact of papers produced by Robert D. Legare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. Legare. The network helps show where Robert D. Legare may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert D. Legare, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 94 | |
| 2 | 2020 | 89 | |
| 3 | 2015 | 87 | |
| 4 | 2009 | 85 | |
| 5 | 2010 | 69 | |
| 6 | 2009 | 62 | |
| 7 | 2006 | 56 | |
| 8 | 2005 | 36 | |
| 9 | 1998 | 34 | |
| 10 | 2009 | 31 | |
| 11 | 2010 | 19 | |
| 12 | 2002 | 19 | |
| 13 | 2004 | 17 | |
| 14 | 1997 | 15 | |
| 15 | 1995 | 12 | |
| 16 | 2000 | 12 | |
| 17 | 2008 | 10 | |
| 18 | 1998 | 10 | |
| 19 | 2015 | 9 | |
| 20 | 2019 | 9 |
About Robert D. Legare
Robert D. Legare is a scholar working on Oncology, Cancer Research, Genetics, Hematology and Reproductive Medicine, having authored 35 papers that have together received 827 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Breast Cancer Treatment Studies (7 papers), BRCA gene mutations in cancer (6 papers), HER2/EGFR in Cancer Research (5 papers), Acute Myeloid Leukemia Research (4 papers), Ovarian cancer diagnosis and treatment (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Drug-Induced Adverse Reactions (3 papers). The work is most often cited by research in Oncology (344 citations), Cancer Research (165 citations), Genetics (193 citations), Reproductive Medicine (55 citations) and Hematology (68 citations). Robert D. Legare has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Don S. Dizon, Ashley Stuckey, Tina Rizack, C.O. Granai, Jorge J. Castillo, Anthony Mega, Rochelle Strenger, William M. Sikov, Katina Robison and Mary Anne Fenton. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Blood, Cancer Research and Obstetrics and Gynecology Clinics of North America.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.